OIS – ISRAEL Ophthalmology Innovation Summit 2024

Year in Review by Nahum Ferera, CEO and Co Founder, EyeYon Medical

Interview with Laurent Attias, Head Corp. Develop, ALCON

Interview with Susan Benton, President, Théa Group

Panel Discussion: Pre Launch

Panel Discussion: Past and Future in Ophthalmology

Presentation by Lumenis: Launching A New Product in Eye Care

Panel Discussion: Post Launch

Panel Discussion: Investors

Company Presentations – Pre-Clinical Stage: OphRx

Company Presentations – Pre-Clinical Stage: Supra Medical

Company Presentations – Pre-Clinical Stage: Blink Energy

Company Presentations – Pre-Clinical Stage: Precise Bio

Company Presentations – Pre-Clinical Stage: I-OPtsens

Company Presentations – Clinical Stage: DiagnosTear

Company Presentation – Clinical Stage: Cell Cure Neurosciences Ltd.

Company Presentation – Clinical Stage: Everads Therapy

Company Presentation – Clinical Stage: CorNeat Vision

Company Presentation – Clinical Stage: Tarsier Pharma

Company Presentations – Post Approval Stage: Peripherex

Company Presentations – Post Approval Stage: Neuro Trigger Ltd.

Company Presentations – Post Approval Stage: MIKAJAKI, SA

Company Presentations – Post Approval Stage: EyeYon Hyper-CL

Company Presentations – Post Approval Stage: Sanoculis

Company Presentations – Post Approval Stage: Nova Sight